For many diabetes patients, their Actos prescription is a chance to manage a disease that dominates their lives. Pioglitazone treatments such as Actos, however, also impose a number of health risks, including the possibility that patients will develop bladder cancer if they take Actos beyond one year.
The Food and Drug Administration (FDA) has issued a warning to manufacturers, physicians, and patients about the side effects of Actos, but other health organizations have been even more aggressive steps. On the basis of a French study, for instance, France suspended the use of pioglitazone altogether and Germany recommended that doctors not prescribe pioglitazone to new patients. The response to Actos by the international health community raises important questions about whether the manufacturers of pioglitazone treatments have taken the appropriate steps to warn patients about the potentially lethal side effects of this dangerous drug.
The Actos lawyers of Fears Nachawati are prepared to fight in courtrooms across the country to protect diabetes patients who have been hurt by Actos. Have you or a loved one been slammed with the news that Actos may have contributed to bladder cancer? You don’t have to suffer alone. We can help you stand up for your rights. Your free consultation with an experienced Actos attorney is just a phone call or email away. Call us today at 1.866.545.8364 or email mn@fnlawfirm.com.